| Trinidad and Tobago | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 193.9 (2020) [72/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 3.8 (2020) [90/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.9 (2020) [120/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 56.2 (2020) [67/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 19.8 (2020) [56/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 28.3 (2020) [64/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 20.5 (2020) [10/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.8 (2020) [64/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 3.8 (2020) [70/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.3 (2020) [103/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.6 (2020) [80/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.7 (2020) [110/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 3.0 (2020) [167/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 11.4 (2020) [98/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 0.8 (2020) [178/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 3.0 (2020) [34/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [117/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 7.8 (2020) [64/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.4 (2020) [128/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.7 (2020) [79/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 11.6 (2020) [10/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 4.9 (2020) [70/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 89.2 (2020) [16/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 4.0 (2020) [139/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 1.6 (2020) [77/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 4.5 (2020) [86/184countries] | | |
|
| Trinidad and Tobago | | |
Suicide, age-standardized (per 100 000 population) | 8.28 (2019) [90/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 13.09 (2019) [95/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 3.66 (2019) [96/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 12.91 (2019) [29/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 17.38 (2019) [31/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 8.34 (2019) [19/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 12.68 (2019) [45/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 19.89 (2019) [43/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 5.39 (2019) [43/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 10.52 (2019) [81/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 16.77 (2019) [80/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.31 (2019) [77/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 10.21 (2019) [108/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 18.21 (2019) [97/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 2.49 (2019) [138/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 8.77 (2019) [127/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 15.81 (2019) [116/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 2.13 (2019) [147/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 7.83 (2019) [138/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 13.73 (2019) [130/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.62 (2019) [146/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 9.51 (2019) [138/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 17.62 (2019) [131/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 3.56 (2019) [140/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 13.20 (2019) [147/183countries] | | |
|
|